Epic sciences unveils new liquid biopsy test to predict sensitivity to PARP inhibitors in prostate cancer trial

April 9, 2019 Leave a comment

Epic Sciences, Inc. and its research partners today report the use of the company’s new circulating tumor cell (CTC) homologous recombination deficiency (HRD) liquid biopsy assay for the prediction of...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Epic Science

Epic sciences unveils new liquid biopsy test to predict sensitivity to PARP inhibitors in prostate cancer trial

Chloride ion channel ASOR is required for vesicle shrinkage

Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles

Damage-free and time-saving platform for continuous sorting and detection of exosomes and host cells in human serum

Predicine Liquid Biopsy Outperforms Four Other Leading ctDNA NGS Tests in a Study by Bristol Myers Squibb

Exosomes and their roles in the chemoresistance of pancreatic cancer

VivaZome to collaborate with the University of Queensland traumatic brain injury experts to develop exosome-based therapies